February 2017 Highlights

Om avsnittet

This month, Executive Editor Michael Roy discusses the use of stimulants and performance enhancers as a possible risk factor for PTSD, behavioral and brain markers of overgeneralized fear conditioning in PTSD, the epidemiology of first-episode psychosis, predictors of suicidal behavior, neural predictors of initiating alcohol use during adolescence, and mediation of placebo effects by patient expectancy in antidepressant clinical trials. Articles may be viewed online at ajp.psychiatryonline.org.

Om avsnittet

Fler avsnitt

October 2026: The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions

September 2026: Circadian Rhythm Stabilization App to Prevent Mood Episode Recurrence in Patients With Mood Disorders: A Multicenter, Double-Blind, Sham-Controlled, Randomized Clinical Trial

81: Psychiatric Risk Associated With Large Language Model Chatbots: An Emerging Concern

August 2026: Cognitive, Electrophysiological, and Behavioral Presentation of First-Episode Psychosis With or Without Cannabis Exposure

July 2026: Social Determinants of Health in Psychiatric Disorders: Exciting Opportunities for Biopsychosocial Research and Clinical Care

June 2026: Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Special Episode: The Future of DSM

May 2026: Psychiatric Comorbidities in Substance Use Disorders: Sex-Based Differences in a National Real-World Clinical Sample

April 2026: Mobile Health for Alcohol Use Assessment: Longitudinal Effects of Breathalyzer Self-Monitoring in Everyday Contexts

March 2026: Primary Prevention of PTSD Symptoms in Combat-Deploying Soldiers Using Attention Bias Modification: A Randomized Controlled Trial